The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / RheumPAC Announces New Donor Benefits in 2020

RheumPAC Announces New Donor Benefits in 2020

February 20, 2020 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

RheumPAC is excited to announce new benefits and giving levels for donors in 2020. The PAC’s success is due to the support of individual contributions, and the committee wants to reward and thank its most ardent supporters in 2020.

You Might Also Like
  • Last Call for 2019 RheumPAC Contributions
  • 2019 RheumPAC Matching Campaign Donors Recognized
  • RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts
Also By This Author
  • Rheumatology Coding Corner Questions: 2017 End-of-Year Quiz

RheumPAC contributions enable the ACR to educate key legislators and their staff about the critical issues rheumatologists and rheumatology interprofessional team members face. Every dollar raised goes directly to the re-election campaigns of legislative leaders to help those who best understand our issues remain in Congress.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Because these contributions are so important to advancing the ACR’s legislative efforts, the RheumPAC Committee encourages everyone to step up to the next donation level this year. Log in to see your 2019 donation level, and make a donation today. Your continued support is greatly appreciated—every contribution helps in the fight to make our voice and the voices of our patients heard in Washington, D.C.

If you have trouble accessing the site or have any questions, contact Dan Redinger, manager of ACR advocacy & political affairs.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Table of RheumPAC donor benefits

 


Contributions to RheumPAC are used for political purposes and are not tax deductible for federal income tax purposes. All contributions to RheumPAC are voluntary and must be made with personal funds. You may refuse to contribute without reprisal. Any proposed contribution amounts are merely suggestions; you may choose to contribute more or less or not at all. RheumPAC will not favor or disadvantage anyone by reason of the amount contributed or the decision not to contribute. Federal law prohibits contributions from corporations. RheumPAC participants must be U.S. citizens or permanent resident aliens.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Legislation & Advocacy Tagged With: donation, RheumPAC

You Might Also Like:
  • Last Call for 2019 RheumPAC Contributions
  • 2019 RheumPAC Matching Campaign Donors Recognized
  • RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts
  • Advocacy Up Close: Dr. Gary Bryant Discusses the Role & Benefits of RheumPAC

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)